NPM1 and acute myeloid leukemia: However, on the basis of previous reports on the higher frequency of cytogenetic abnormalities among Iranian AML patients,35 it can be said that it is not unlikely that the above-stated fact has accounted for the lower frequency of NPM1 mutations in our results.